128 related articles for article (PubMed ID: 23466786)
1. Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.
Wang W; Chen X; Li T; Li Y; Wang R; He D; Luo W; Li X; Wu X
Exp Cell Res; 2013 May; 319(8):1156-64. PubMed ID: 23466786
[TBL] [Abstract][Full Text] [Related]
2. A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.
Li T; Luo W; He D; Wang R; Huang Y; Zeng X; Wang W; Chen X; Gao S; Yu Y; Li X; Wu X
Cancer Lett; 2013 Oct; 339(2):226-36. PubMed ID: 23774400
[TBL] [Abstract][Full Text] [Related]
3. A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
Maruyama-Takahashi K; Shimada N; Imada T; Maekawa-Tokuda Y; Ishii T; Ouchi J; Kusaka H; Miyaji H; Akinaga S; Tanaka A; Shitara K
Prostate; 2008 May; 68(6):640-50. PubMed ID: 18213631
[TBL] [Abstract][Full Text] [Related]
4. A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.
Giacomini A; Matarazzo S; Pagano K; Ragona L; Rezzola S; Corsini M; Di Salle E; Presta M; Ronca R
Oncotarget; 2015 May; 6(15):13790-802. PubMed ID: 25912421
[TBL] [Abstract][Full Text] [Related]
5. A short peptide reverses the aggressive phenotype of prostate cancer cells.
Liu H; Lin X; Huang T; Song L; Zhu C; Ma H; Long T; Zeng H; Li R; Wang H; Huang Y; Chen L; Wu X
Eur J Pharmacol; 2018 Nov; 838():129-137. PubMed ID: 30196111
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library.
Dai X; Cai C; Xiao F; Xiong Y; Huang Y; Zhang Q; Xiang Q; Lou G; Lian M; Su Z; Zheng Q
Biochem Biophys Res Commun; 2014 Mar; 445(4):795-801. PubMed ID: 24530908
[TBL] [Abstract][Full Text] [Related]
7. An FGF8b-mimicking peptide with potent antiangiogenic activity.
Lin X; Song L; He D; Zeng X; Wu J; Luo W; Yang Q; Wang J; Wang T; Cai J; Lin Y; Lai F; Peng W; Wu X
Mol Med Rep; 2017 Jul; 16(1):894-900. PubMed ID: 28560418
[TBL] [Abstract][Full Text] [Related]
8. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
Olsen SK; Li JY; Bromleigh C; Eliseenkova AV; Ibrahimi OA; Lao Z; Zhang F; Linhardt RJ; Joyner AL; Mohammadi M
Genes Dev; 2006 Jan; 20(2):185-98. PubMed ID: 16384934
[TBL] [Abstract][Full Text] [Related]
9. Screening a novel FGF3 antagonist peptide with anti-tumor effects on breast cancer from a phage display library.
Wang W; Chen T; Li H; Chen Y; Wu Z; Feng T; Zhang X; Zhong Q; Zhong Q; Li G; Guo L; Zhou L; Zhou J
Mol Med Rep; 2015 Nov; 12(5):7051-8. PubMed ID: 26323695
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms.
Ghosh AK; Shankar DB; Shackleford GM; Wu K; T'Ang A; Miller GJ; Zheng J; Roy-Burman P
Cell Growth Differ; 1996 Oct; 7(10):1425-34. PubMed ID: 8891346
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of FGF8b regulation of epithelial-mesenchymal transition in prostate cancer cells].
Fan B; Wang G; Qi F; Li Z; Liu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):656-61. PubMed ID: 22886216
[TBL] [Abstract][Full Text] [Related]
12. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
[TBL] [Abstract][Full Text] [Related]
13. FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.
Wang J; Tan X; Guo Q; Lin X; Huang Y; Chen L; Zeng X; Li R; Wang H; Wu X
Pharmacol Res; 2020 Feb; 152():104575. PubMed ID: 31805343
[TBL] [Abstract][Full Text] [Related]
14. Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells.
Bashari O; Redko B; Cohen A; Luboshits G; Gellerman G; Firer MA
Cancer Lett; 2017 Nov; 408():164-173. PubMed ID: 28888997
[TBL] [Abstract][Full Text] [Related]
15. FGF8 isoform b expression in human prostate cancer.
Gnanapragasam VJ; Robinson MC; Marsh C; Robson CN; Hamdy FC; Leung HY
Br J Cancer; 2003 May; 88(9):1432-8. PubMed ID: 12778074
[TBL] [Abstract][Full Text] [Related]
16. Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.
Leali D; Alessi P; Coltrini D; Ronca R; Corsini M; Nardo G; Indraccolo S; Presta M
Mol Cancer Ther; 2011 Sep; 10(9):1600-10. PubMed ID: 21764903
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of ERβ and prostate tumorigenesis in FGF8b transgenic mice.
Elo T; Yu L; Valve E; Mäkelä S; Härkönen P
Endocr Relat Cancer; 2014 Aug; 21(4):677-90. PubMed ID: 24938408
[TBL] [Abstract][Full Text] [Related]
18. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.
Romanov VI; Durand DB; Petrenko VA
Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171
[TBL] [Abstract][Full Text] [Related]
19. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.
Tuomela J; Grönroos TJ; Valta MP; Sandholm J; Schrey A; Seppänen J; Marjamäki P; Forsback S; Kinnunen I; Solin O; Minn H; Härkönen PL
BMC Cancer; 2010 Oct; 10():596. PubMed ID: 21034500
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).
Shen D; Xie F; Edwards WB
PLoS One; 2013; 8(7):e68339. PubMed ID: 23935860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
